Xtandi - 40 mg film-coated tablets

  • DHPC
Active Ingredient
Strength
  • Enzalutamide: 40 mg
Dosage Form
Film-coated tablet
Legal Category
A - prescription, may not be renewed
Last Updated
25/09/2026
Additional Communications section shown.

Direct Healthcare Professional Communications

  • DHPC enzalutamide test interference leading to falsely elevated digoxin plasma levels

    Direct Healthcare Professional Communication (DHPC)

    PDF366.65 KB

Astellas Pharma Co. Ltd

Damastown Road, Damastown Industrial Park, Mulhuddart, Dublin 15